甲氨蝶呤用于系统性红斑狼疮
Methotrexate in systemic lupus erythematosus.
作者信息
Walz LeBlanc B A, Dagenais P, Urowitz M B, Gladman D D
机构信息
Lupus Clinic, Wellesley Hospital, Toronto, ON, Canada.
出版信息
J Rheumatol. 1994 May;21(5):836-8.
OBJECTIVE
Methotrexate (MTX) has been used successfully in the treatment of rheumatoid arthritis, psoriatic arthritis, polymyositis, and Reiter's syndrome. Our objective was to determine the effectiveness of MTX in the treatment of systemic lupus erythematosus (SLE).
METHODS
We reviewed retrospectively MTX therapy in 5 patients with SLE, 3 with renal disease and 2 with arthritis.
RESULTS
MTX therapy was well tolerated and effective in all 5 patients.
CONCLUSION
MTX appears to be both effective and well tolerated in patients with SLE.
目的
甲氨蝶呤（MTX）已成功用于治疗类风湿关节炎、银屑病关节炎、多发性肌炎和赖特综合征。我们的目的是确定MTX治疗系统性红斑狼疮（SLE）的有效性。
方法
我们回顾性分析了5例SLE患者的MTX治疗情况，其中3例有肾脏疾病，2例有关节炎。
结果
所有5例患者对MTX治疗耐受性良好且有效。
结论
MTX在SLE患者中似乎既有效且耐受性良好。
Zotero 插件